MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0289929

Медицинская библиотека · PloS one · 2023

Examination of ELISA against PCR for assessing treatment efficacy against Cryptosporidium in a clinical trial context.

Nyirenda James T, Henrion Marc Y R, Nyasulu Vita, Msakwiza Mike, Nedi Wilfred, Thole Herbert, Phulusa Jacob, Toto Neema, Jere Khuzwayo C, Winter Alex, Sawyer Leigh A, Conrad Thomas, Hebert Donnie, Chen Crystal, Van Voorhis Wesley C, Houpt Eric R, Iroh Tam Pui-Ying, Operario Darwin J

Рандомизированное исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Cryptosporidium is a gastrointestinal pathogen that presents a serious opportunistic infection in immunocompromised individuals including those living with human immunodeficiency syndrome. The CRYPTOFAZ trial, previously published, was conducted in Malawi to evaluate the efficacy of clofazimine in response to an unmet need for drugs to treat cryptosporidiosis in HIV populations. A combination of rapid diagnostic tests, ELISA, qPCR, and conventional sequencing were employed to detect Cryptosporidium in 586 individuals during pre-screening and monitor oocyst shedding and identify enteric co-pathogens in 22 enrolled/randomized participants during the in-patient period and follow-up visits.

METHODOLOGY: Oocyst shedding as measured by qPCR was used to determine primary trial outcomes, however pathogen was detected even at trial days 41-55 in individuals randomized to either clofazimine or placebo arms of the study. Therefore, in this work we re-examine the trial outcomes and conclusions in light of data from the other diagnostics, particularly ELISA. ELISA data was normalized between experiments prior to comparison to qPCR. The amount of all identified enteric pathogens was examined to determine if co-pathogens other than Cryptosporidium were major causative agents to a participant's diarrhea.

CONCLUSION

ELISA had higher sample-to-sample variability and proved to be equally or less sensitive than qPCR in detecting Cryptosporidium positive samples. Compared to qPCR, ELISA had equal or greater specificity in detecting Cryptosporidium negative samples. Sequencing identified several Cryptosporidium species including viatorum which has never been identified in Malawi and Southern Africa. In addition to Cryptosporidium, enterotoxigenic E. coli was also identified as a pathogen in diarrheagenic amounts in 4 out of 22 participants.

Для цитирования: Nyirenda James T, Henrion Marc Y R, Nyasulu Vita, Msakwiza Mike, Nedi Wilfred, Thole Herbert, Phulusa Jacob, Toto Neema, Jere Khuzwayo C, Winter Alex, Sawyer Leigh A, Conrad Thomas, Hebert Donnie, Chen Crystal, Van Voorhis Wesley C, Houpt Eric R, Iroh Tam Pui-Ying, Operario Darwin J. Examination of ELISA against PCR for assessing treatment efficacy against Cryptosporidium in a clinical trial context.. PloS one. 2023. DOI: 10.1371/journal.pone.0289929.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.